Nidal Al-Huniti

Nidal Al-Huniti

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4415546
-
person_outline Nidal Al-Huniti's MOST POPULAR ARTICLES
1-) The identification of potent, selective, and orally available inhibitors of ataxia telangiectasia mutated (ATM) kinase: the discovery of AZD0156 (8-{6-[3-(Dimethylamino … Journal of medicinal chemistry 61 (9), 3823-3841, 2018
2-) Hypercholesterolemia is a potential risk factor for asthma Journal of Asthma 43 (3), 231-233, 2006
3-) The identification of potent, selective, and orally available inhibitors of ataxia telangiectasia mutated (ATM) kinase: the discovery of AZD0156 (8-{6-[3-(Dimethylamino …KG Pike, B Barlaam, E Cadogan, A Campbell, Y Chen, N Colclough, ...Journal of medicinal chemistry 61 (9), 3823-3841, 20181202018
4-) Multiple‐dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsR Krishna, AJ Bergman, B Jin, M Fallon, J Cote, P Van Hoydonck, ...Clinical Pharmacology & Therapeutics 84 (6), 679-683, 20081072008
5-) Hypercholesterolemia is a potential risk factor for asthmaB Al-Shawwa, N Al-Huniti, G Titus, M Abu-HasanJournal of Asthma 43 (3), 231-233, 20061072006